73 participants
Outcomes of Unfit Patients With CLL Included in the GIMEMA LLC1114 Trial Who Discontinued Ibrutinib Due to Reasons Other Than Disease Progression
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2024-04-10
- Start Date:
- 2024-05-31
- Completion:
- 2026-05-31
Conditions
- Chronic Lymphocytic Leukemia
Interventions
- OTHER
No Results Yet